CY1116636T1 - DETERGENTS OF tetrahydroazolone and tetrahydroazolone - Google Patents

DETERGENTS OF tetrahydroazolone and tetrahydroazolone

Info

Publication number
CY1116636T1
CY1116636T1 CY20151100025T CY151100025T CY1116636T1 CY 1116636 T1 CY1116636 T1 CY 1116636T1 CY 20151100025 T CY20151100025 T CY 20151100025T CY 151100025 T CY151100025 T CY 151100025T CY 1116636 T1 CY1116636 T1 CY 1116636T1
Authority
CY
Cyprus
Prior art keywords
compounds
tetrahydroazolone
detergents
formula
disclosed
Prior art date
Application number
CY20151100025T
Other languages
Greek (el)
Inventor
Kenneth He Huang
Jeron Eaves
James Veal
Thomas Barta
Lifeng Geng
Lindsay Hinkley
Gunnar Hanson
Original Assignee
Esanex, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06736330.9A external-priority patent/EP1856057B1/en
Application filed by Esanex, Inc. filed Critical Esanex, Inc.
Publication of CY1116636T1 publication Critical patent/CY1116636T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αποκαλύπτονται ενώσεις και φαρμακευτικά αποδεκτά άλατα του Χημικού Τύπου (I): όπου τα R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Υ και τα Χ1-Χ4 είναι όπως προσδιορίζονται στο παρόν. Οι ενώσεις του Χημικού Τύπου (I) είναι χρήσιμες στη θεραπεία παθήσεων και/ή καταστάσεων που σχετίζονται με τον κυτταρικό πολλαπλασιασμό, όπως ο καρκίνος, η φλεγμονή, η αρθρίτιδα, η αγγειογένεση και άλλα παρόμοια. Αποκαλύπτονται επίσης φαρμακευτικές συνθέσεις που περιλαμβάνουν ενώσεις της εφεύρεσης και μεθόδους θεραπείας των προαναφερθεισών καταστάσεων με τη χρήση αυτών των ενώσεων.Compounds and pharmaceutically acceptable salts of Formula (I) are disclosed: wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y and X1-X4 are as defined herein. The compounds of Formula (I) are useful in the treatment of diseases and / or conditions associated with cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using these compounds.

CY20151100025T 2005-02-25 2015-01-12 DETERGENTS OF tetrahydroazolone and tetrahydroazolone CY1116636T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65623005A 2005-02-25 2005-02-25
US70571505A 2005-08-04 2005-08-04
US72796505A 2005-10-18 2005-10-18
EP06736330.9A EP1856057B1 (en) 2005-02-25 2006-02-27 Tetrahydroindolone and tetrahydroindazolone derivatives

Publications (1)

Publication Number Publication Date
CY1116636T1 true CY1116636T1 (en) 2017-03-15

Family

ID=58459806

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100025T CY1116636T1 (en) 2005-02-25 2015-01-12 DETERGENTS OF tetrahydroazolone and tetrahydroazolone

Country Status (1)

Country Link
CY (1) CY1116636T1 (en)

Similar Documents

Publication Publication Date Title
UA92907C2 (en) Tetrahydroindazolone derivatives
PE20110547A1 (en) ISOINDOLINE COMPOUNDS WITH ANTI-CANCER ACTIVITY
CY1110247T1 (en) Benzokinazoline derivatives and their use in the treatment of bone disorders
CY1122349T1 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CXCR1 AND P40
CY1116103T1 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
CY1110419T1 (en) Tricyclic compounds based on 1,6-dihydro-1,3,5,6-TETPAAZA-AS-INDAKENE and PHARMACEUTICAL COMPOSITIONS CONTAINING AS INCORRECT
CY1123626T1 (en) HETEROCYCLIC PROTEIN KINASE INHIBITORS
CY1108094T1 (en) KINOLIN PRODUCTS AS PHOSPHOSTERATION INFLUENCES
CY1114861T1 (en) 3-ARYLAMINOPYRIDINE PRODUCT
CY1109644T1 (en) 2,4-DIAMINO-PYRAMIDINES AS AUDORA Suspensions
CY1121804T1 (en) NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR USE
CY1108183T1 (en) THIAZOLYLO-DIDHRO-INDAZOLIA
CY1117776T1 (en) SPIRIT-OXIDOLI COMPOUNDS ANTIOMETER AND THEIR USES AS A THERAPEUTIC AGENT
CY1113324T1 (en) Substituted Amide Derivatives as Protein Kinase Suspensions
CY1114737T1 (en) KINOXALINDION PRODUCTS
CY1113114T1 (en) Inhibitors of E1 Activation Enzymes
CY1113323T1 (en) [3,4-D] DIOXOLANIUM COMPOUNDS FOR USE IN THE TREATMENT OF VIRUS INFECTIONS AND CANCER
CY1117504T1 (en) 1-Benzyl-3-hydroxymethyldazole derivative and their use in the therapeutic treatment of MCP-1 and MCP-1-expressing diseases
CY1113166T1 (en) Inhibitors of E1 Activation Enzymes
CY1106405T1 (en) QUINAZOLINE DERIVATIVES
CY1114793T1 (en) Aminoprazole derivatives
WO2007035620A3 (en) Carbazole derivatives
CY1120420T1 (en) SULFONYLOPEPERININ PRODUCTS AND THEIR USE FOR THE PROTECTION OF PROCINETINE MEDIATION
CY1109322T1 (en) PROLINE PRODUCERS AND THEIR USE AS DIPLOMATIC PIPES
GB0510584D0 (en) Organic compounds